XML 25 R7.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total Ready Capital Corporation Equity
Cumulative Effect, Period of Adoption, Adjustment
Total Ready Capital Corporation Equity
Preferred stock
Series B Preferred Stock
Preferred stock
Series D Preferred Stock
Common Stock
Additional Paid-in-Capital
Retained Earnings (Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Deficit)
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests
Cumulative Effect, Period of Adoption, Adjustment
Total
Balance at beginning of period at Dec. 31, 2019 $ (6,599) $ 825,412     $ 5 $ 822,837 $ (6,599) $ 8,746 $ (6,176) $ (155) $ 19,372 $ (6,754) $ 844,784
Balance at beginning of period (in shares) at Dec. 31, 2019         51,127,326                
Increase (Decrease) in Stockholders' Equity                          
Dividend declared on common stock   (21,300)           (21,300)         (21,300)
Dividend declared on OP units                     (447)   (447)
Equity issuances   13,410       13,410             13,410
Equity issuances (shares)         900,000                
Offering costs   (38)       (38)         (1)   (39)
Equity component of 2017 convertible note issuance   (92)       (92)         (2)   (94)
Stock-based compensation   894       894             894
Stock-based compensation (shares)         60,370                
Manager incentive fee paid in stock   53       53             53
Manager incentive fee paid in stock (shares)         4,154                
Net income (loss)   (50,452)           (50,452)     (1,064)   (51,516)
Other comprehensive income (loss)   (3,360)             (3,360)   (72)   (3,432)
Balance at end of period at Mar. 31, 2020   757,928     $ 5 837,064   (69,605) (9,536)   17,631   775,559
Balance at end of period (in shares) at Mar. 31, 2020         52,091,850                
Balance at beginning of period at Dec. 31, 2020   815,396     $ 5 849,541   (24,203) (9,947)   18,812   834,208
Balance at beginning of period (in shares) at Dec. 31, 2020         54,368,999                
Increase (Decrease) in Stockholders' Equity                          
Dividend declared on common stock   (23,833)           (23,833)         (23,833)
Dividend declared on OP units                     (470)   (470)
Dividend declared - $0.5390625 per Series B preferred share   (126)           (126)     (1)   (127)
Dividend declared - $0.390625 per Series C preferred share   (37)           (37)         (37)
Dividend declared - $0.4765625 per Series D preferred share   (116)           (116)     (1)   (117)
Shares issued pursuant to merger transactions   337,778 $ 47,984 $ 50,257 $ 2 239,535             337,778
Shares issued pursuant merger to merger transactions (shares)     1,919,378 2,010,278 16,774,337                
Equity component of 2017 convertible note issuance   (99)       (99)         (2)   (101)
Stock-based compensation   522       522             522
Stock-based compensation (shares)         115,604                
Share repurchases   (987)       (987)             (987)
Share repurchases (shares)         (37,241)                
Net income (loss)   28,288           28,288     659   28,947
Other comprehensive income (loss)   2,905             2,905   64   2,969
Balance at end of period at Mar. 31, 2021   $ 1,159,691 $ 47,984 $ 50,257 $ 7 $ 1,088,512   $ (20,027) $ (7,042)   $ 19,061   $ 1,178,752
Balance at end of period (in shares) at Mar. 31, 2021     1,919,378 2,010,278 71,221,699